New Zealand links 26-year-old man's death to Pfizer Covid-19 vaccine
Gulf Times
A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021.
New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's (PFE.N) Covid-19 vaccine after the person suffered myocarditis, a rare inflammation of the heart muscle, after taking his first dose.
The death is New Zealand's second linked to a known but rare side effect from the vaccine after health authorities in August reported a woman had died after taking her doses.
"With the current available information, the board has considered that the myocarditis was probably due to vaccination in this individual," a Covid-19 Vaccine Independent Safety Monitoring Board said in a statement.
The man, who died within two weeks of his first dose, had not sought medical advice or treatment for his symptoms. Myocarditis is an inflammation of the heart muscle that can limit the organ's ability to pump blood and can cause changes in heartbeat rhythms.
